Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma

Clinical trial NCT07147361 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07147361
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Esophageal Squamous Cell Carcinoma (ESCC)Cervical Squamous Cell Carcinoma Lung Squamous Cell Carcinoma Head and Neck Squamous Carcinoma

Start date: 2020-05-28
Primary completion: 2026-12-31
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.